secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2022-04-15T23:59:59+00:00
Accession:  0000950142-22-001414
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics executive chairperson Robin Abrams resigns, will not stand for reelection
--------------------------------------------------------------------------------

- Robin E. Abrams resigned as executive chairperson of the Board effective April 15, 2022.
- Abrams will remain a member of the Board but will not stand for reelection at the 2022 annual meeting.
- Resignation is not due to any disagreement with company operations, policies, or practices.
- No replacement named; Richard S. Nelson continues as Interim CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222001414/0000950142-22-001414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222001414/eh220244727_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950142-22-001414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer